Is radiofrequency ablation effective in patients with early-stage hepatocellular carcinoma and cirrhosis?
S Nahum Goldberg
Correspondence Department of Radiology, Beth Israel Deaconess Medical Center, 1 Deaconess Road, CC-308, Boston, MA 02215, USA
Email sgoldber@bidmc.harvard.edu
This article has no abstract so we have provided the first paragraph of the full text.
Over the past decade, there has been increased interest in image-guided RFA of focal tumors using needle-like applicators because of the minimal morbidity and mortality compared with conventional surgical resection.1 Clinical interest has focused upon treating HCC because most patients have underlying liver disease and/or coagulopathies, which substantially increase surgical morbidity, and most patients develop additional foci of disease.1, 2, 3, 4
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.